StockData
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. (SNOA) stock

SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3082% below fair value
$0.83−0.05 (-5.21%)

Close on Nov 17, 2026Market cap $3.99MP/E –Yield –

Sonoma Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Sonoma Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$2.57M. For fiscal 2026 it was -$3.93M. The highest annual figure on record is $1.15M in fiscal 2013.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$3.93M–
FY2025Mar 31, 2025-$88.00K–
FY2024Mar 31, 2024-$2.40M–
FY2023Mar 31, 2023-$6.15M–
FY2022Mar 31, 2022-$4.25M–
FY2021Mar 31, 2021-$3.38M–
FY2020Mar 31, 2020-$4.59M–
FY2019Mar 31, 2019-$11.72M–
FY2018Mar 31, 2018-$12.44M–
FY2017Mar 31, 2017-$8.17M–
FY2016Mar 31, 2016-$8.75M–
FY2015Mar 31, 2015-$6.69M–
FY2014Mar 31, 2014-$4.89M-525.2%
FY2013Mar 31, 2013$1.15M–
FY2012Mar 31, 2012-$4.03M–
FY2011Mar 31, 2011-$4.43M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026-$649.00K–
Q4 FY2026CQ1 2026Mar 31, 2026-$519.00K–
Q3 FY2026CQ4 2025Dec 31, 2025-$764.00K-235.2%
Q2 FY2026CQ3 2025Sep 30, 2025-$635.00K-279.4%
Q1 FY2026CQ2 2025Jun 30, 2025-$2.02M–
Q4 FY2025CQ1 2025Mar 31, 2025-$95.00K-162.5%
Q3 FY2025CQ4 2024Dec 31, 2024$565.00K–
Q2 FY2025CQ3 2024Sep 30, 2024$354.00K–
Q1 FY2025CQ2 2024Jun 30, 2024-$912.00K–
Q4 FY2024CQ1 2024Mar 31, 2024$152.00K–
Q3 FY2024CQ4 2023Dec 31, 2023-$1.10M–
Q2 FY2024CQ3 2023Sep 30, 2023-$1.23M–
Q1 FY2024CQ2 2023Jun 30, 2023-$215.00K–
Q4 FY2023CQ1 2023Mar 31, 2023-$2.44M–
Q3 FY2023CQ4 2022Dec 31, 2022-$348.00K–
Q2 FY2023CQ3 2022Sep 30, 2022-$1.83M–
Q1 FY2023CQ2 2022Jun 30, 2022-$1.53M–
Q4 FY2022CQ1 2022Mar 31, 2022-$1.40M–
Q3 FY2022CQ4 2021Dec 31, 2021-$326.00K-143.7%
Q2 FY2022CQ3 2021Sep 30, 2021-$1.30M–
Q1 FY2022CQ2 2021Jun 30, 2021-$1.22M–
Q4 FY2021CQ1 2021Mar 31, 2021-$1.48M–
Q3 FY2021CQ4 2020Dec 31, 2020$746.00K–
Q2 FY2021CQ3 2020Sep 30, 2020-$357.00K–
Q1 FY2021CQ2 2020Jun 30, 2020-$2.29M-410.4%
Q4 FY2020CQ1 2020Mar 31, 2020-$3.59M–
Q3 FY2020CQ4 2019Dec 31, 2019-$840.00K–
Q2 FY2020CQ3 2019Sep 30, 2019-$898.00K–
Q1 FY2020CQ2 2019Jun 30, 2019$738.00K–
Q4 FY2019CQ1 2019Mar 31, 2019-$2.75M–
Q3 FY2019CQ4 2018Dec 31, 2018-$2.36M–
Q2 FY2019CQ3 2018Sep 30, 2018-$3.55M–
Q1 FY2019CQ2 2018Jun 30, 2018-$3.06M–
Q4 FY2018CQ1 2018Mar 31, 2018-$3.05M–
Q3 FY2018CQ4 2017Dec 31, 2017-$2.16M–
Q2 FY2018CQ3 2017Sep 30, 2017-$2.60M–
Q1 FY2018CQ2 2017Jun 30, 2017-$4.63M–
Q4 FY2017CQ1 2017Mar 31, 2017-$2.70M–
Q3 FY2017CQ4 2016Dec 31, 2016-$1.47M–
Q2 FY2017CQ3 2016Sep 30, 2016-$1.62M–

More Sonoma Pharmaceuticals figures

See a number that looks wrong?